The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

Jasmohan S. Bajaj, K. Rajender Reddy, Puneeta Tandon, Florence Wong, Patrick S. Kamath, Guadalupe Garcia‐Tsao, Benedict Maliakkal, Scott W. Biggins, Paul J. Thuluvath, Michael B. Fallon, Ram M. Subramanian, Hugo Vargas, Leroy R. Thacker, Jacqueline G. O'Leary, North American Consortium for the Study of End‐Stage Liver Disease – 21 December 2015 – In smaller single‐center studies, patients with cirrhosis are at a high readmission risk, but a multicenter perspective study is lacking.

Subscribe to